| We represent the needs and concerns of our target population in joint discussions with regulatory authorities and industry stakeholders across a range of networks. | Gynækologisk
> Gynækologisk: andet | Regulatorisk partnerskab
> Arbejde med regulerende myndigheder | 100.000 | National | Sometimes | 115028466428 |
| We periodically prepare statements for submission as supporting documentation to drug reimbursement applications. | Ikke angivet
> Ikke angivet | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 10.000 | National | Sometimes | 114998339214 |
| We periodically prepare submissions to accompany medicine reimbursement applications. | Ikke angivet
> Ikke angivet | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 10.000 | National | Sometimes | 114998339214 |
| We provide formal submissions, and I have personally participated in consultation processes — for example, as part of the working group tasked with developing the pharmaceutical reimbursement system. | Knogle
> Slidgigt | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 10.000 | National | Regularly | 114998343058 |
| Patient organisation submissions to the authorities responsible for reimbursement decisions. | Kræft
> Kræft: bryst | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 10.000 | National | Sometimes | 115043746918 |
| We are a patient organisation representing individuals living with osteoporosis, and we advocate for the patient perspective in all our interactions with regulatory authorities. | Knogle
> Osteoporose | Regulatorisk partnerskab
> Deltag i/faciliter møder med politiske beslutningstagere/regulatorer | 100.000 | National | Regularly | 114998337721 |
| We represent the needs and concerns of our target population in joint discussions with regulatory authorities and industry stakeholders across a range of networks. | Gynækologisk
> Gynækologisk: andet | Regulatorisk partnerskab
> Deltag i/faciliter møder med politiske beslutningstagere/regulatorer | 100.000 | National | Sometimes | 115028466428 |
| We submit statements to regulatory channels from a patient perspective. | Kræft
> Kræft: de fleste typer | Regulatorisk partnerskab
> Deltag i/faciliter møder med politiske beslutningstagere/regulatorer | Do not know | National | Regularly | 115040330840 |
| Occasional position statements and opinions, often issued jointly with another organisation or under the auspices of an umbrella body. | Reumatisk
> Lupus | Regulatorisk partnerskab
> Med andre sundhedsforkæmpere | 5.000 | National | Rarely | 115002845827 |
| Where there is a need to advocate or submit a formal statement, for example, we do so. | Generelt helbred
> Seksuel sundhed: andet | Indflydelse på politik og lovgivning
> Påvirk sundhedspolitik og lovgivning | 10.000 | National | Rarely | 115000148067 |
| We provide formal submissions, and I have personally participated in consultation processes — for example, as part of the working group tasked with developing the pharmaceutical reimbursement system. | Knogle
> Slidgigt | Indflydelse på politik og lovgivning
> Deltag i offentlige høringer og konsultationer | 10.000 | National | Regularly | 114998343058 |
| We submit consultation responses. | Knogle
> Slidgigt | Indflydelse på politik og lovgivning
> Deltag i offentlige høringer og konsultationer | 10.000 | National | Regularly | 114998343058 |
| Engagement with the city and the wellbeing services county to extend free pharmaceutical treatment to type 2 diabetes medicines. | Endokrin
> Diabetes (både type 1 og type 2) | Prisfastsættelse og overkommelighed
> Fortaler for retfærdig medicinprissætning | 1.000 | Regional | Sometimes | 115006989892 |
| Medicine pricing, Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] reimbursement procedures, pharmacy services, and out-of-pocket medicine costs. | Handicap
> Handicap: de fleste typer | Prisfastsættelse og overkommelighed
> Fortaler for retfærdig medicinprissætning | 1.000 | National | Regularly | 115007749998 |
| The price of obesity medicines. | Patientadvokatur
> Sundhedsaktivist | Prisfastsættelse og overkommelighed
> Fortaler for retfærdig medicinprissætning | 1.000 | National | Sometimes | 115060416441 |
| For example, the Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] medicine credit pilot [a Finnish policy experiment designed to help low-income patients afford high-cost prescription medicines when they face a large out-of-pocket payment all at once], which commenced on 27 October and will run for three years. | Hud
> Psoriasis | Prisfastsættelse og overkommelighed
> Adresser omkostningsbarrierer for lavindkomst- og sårbare personer | 10.000 | National | Regularly | 115000293575 |
| Medicine pricing, Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] reimbursement procedures, pharmacy services, and out-of-pocket medicine costs. | Handicap
> Handicap: de fleste typer | Prisfastsættelse og overkommelighed
> Adresser omkostningsbarrierer for lavindkomst- og sårbare personer | 1.000 | National | Regularly | 115007749998 |
| Engagement with the city and the wellbeing services county to extend free pharmaceutical treatment to type 2 diabetes medicines. | Endokrin
> Diabetes (både type 1 og type 2) | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 1.000 | Regional | Sometimes | 115006989892 |
| Patient organisation submissions to promote medicine reimbursement and access. | Neuromuskulær
> Muskeldystrofi | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 5.000 | National | Regularly | 115007479426 |
| Medicine pricing, Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] reimbursement procedures, pharmacy services, and out-of-pocket medicine costs. | Handicap
> Handicap: de fleste typer | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 1.000 | National | Regularly | 115007749998 |
| For example, the Kela [Kansaneläkelaitos – Social Insurance Institution of Finland] medicine credit pilot [a Finnish policy experiment designed to help low-income patients afford high-cost prescription medicines when they face a large out-of-pocket payment all at once], which commenced on 27 October and will run for three years. | Hud
> Psoriasis | Forbedring af adgangsveje
> Fremme retfærdig adgang til medicin/sundhedspleje | 10.000 | National | Regularly | 115000293575 |
| Engagement with the city and the wellbeing services county to extend free pharmaceutical treatment to type 2 diabetes medicines. | Endokrin
> Diabetes (både type 1 og type 2) | Forbedring af adgangsveje
> Fremme retfærdig adgang til medicin/sundhedspleje | 1.000 | Regional | Sometimes | 115006989892 |
| Patient organisation submissions to promote medicine reimbursement and access. | Neuromuskulær
> Muskeldystrofi | Forbedring af adgangsveje
> Fremme retfærdig adgang til medicin/sundhedspleje | 5.000 | National | Regularly | 115007479426 |
| We are a patient organisation representing individuals living with osteoporosis, and we advocate for the patient perspective in all our interactions with regulatory authorities. | Knogle
> Osteoporose | Evidensbaseret patientinput
> Brug patientindsigt til at informere beslutninger | 100.000 | National | Regularly | 114998337721 |
| We submit statements to regulatory channels from a patient perspective. | Kræft
> Kræft: de fleste typer | Evidensbaseret patientinput
> Brug patientindsigt til at informere beslutninger | Do not know | National | Regularly | 115040330840 |
| ... We are represented on Fimea's [Lääkealan turvallisuus- ja kehittämiskeskus – Finnish Medicines Agency] patient advisory board. | Ikke angivet
> Ikke angivet | Institutionel styring
> Sikre repræsentation i statslige rådgivende organer | 10.000 | National | Sometimes | 114998339214 |
interaktioner
handlinger & fortalervirksomhed
8 omtaler
